Focusing on on-site PD measurement strategies, the content discusses intrusive and nonintrusive methods, sensor types, and ...

On Tuesday, Amazon unveiled a new GLP-1 management program aimed at simplifying how patients access, and stay on, high-demand weight loss drugs like Wegovy and Zepbound, a market that has surged in ...

Abnormal expansion of PD-1+ T lymphocytes may be a sign of lupus nephritis onset in patients with SLE. Elevated PD-1+CD4+ T cells represent an independent risk factor for lupus nephritis (LN) and may ...

The Universal Serial Bus (USB) started out as a data interface, but it didn’t take long before progressing to powering devices. Initially, its maximum output was only 2.5 W; now, it can deliver up to ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...

Northrop Grumman has written a new line in the history books, the company's Mission Extension Vehicle 1 (MEV-1) executing the first undocking of two commercial satellites in geosynchronous earth orbit ...

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has hit the goals of a phase 2 rheumatoid arthritis (RA) trial. The phase 2b RENOIR ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in bladder cancer, positioning the Big Pharma to file for approval of an ...

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments. A "checkpoint" receptor that often resides on the surface of ...

On Wednesday, OpenAI launched a 1-800-CHATGPT (1-800-242-8478) telephone number that anyone in the US can call to talk to ChatGPT via voice chat for up to 15 minutes for free. The company also says ...

The days of broad approvals for PD-1 inhibitors in stomach and esophageal cancers appear to be numbered. A group of external advisers to the FDA voted 10-2 that the use of PD-1 inhibitors in ...